Researchers and companies are devising promising approaches to circumvent limitations of existing transfection technologies. Ongoing challenges, particularly with regard to high-quality recombinant ...
Cell and gene therapies are changing lives. They engineer patients’ cells or DNA to create personalized therapies, unlocking long-lasting or even curative treatments for diseases with high unmet needs ...
This research investigates how to optimize mRNA transfection in human T-cells utilizing the jetMESSENGER ® transfection reagent. By using advanced bioanalytical instruments like the Incucyte ® ...
In recent years, AAV manufacturing processes have evolved significantly to not only address the need for later-stage clinical and commercial supplies, but also to address regulatory concerns around ...
insights from industryJames BradySenior Vice PresidentMaxCyte, Inc. In this interview, NewsMedical talks to James Brady about cell-based therapy and how the field of genetic engineering transformed.
WEST BOYLSTON, Mass. & SOUTHBRIDGE, Mass.--(BUSINESS WIRE)--TransCytos: NEVER BEEN DONE BEFORE Enginasion and TransCytos announced today that their collaboration has resulted in a prototype ...
Transfection—the process of introducing exogenous genetic material to cells—is one of the most common techniques used in life sciences laboratories. However, researchers still face challenges when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results